Pharmaceutical - Brilinta

Filter

Current filters:

Brilinta

Popular Filters

Brilinta preferred over clopidogrel in latest AHA/ACC guideline

Brilinta preferred over clopidogrel in latest AHA/ACC guideline

06-10-2014

Anglo-Swedish pharma major AstraZeneca today confirmed that the American Heart Association (AHA) and…

AstraZenecaBrilintaCardio-vascularClopidogrelDaiichi SankyoEli LillyPharmaceuticalprasugrelRegulationSanofiticagrelorUSA

US DoJ closes investigation into AstraZeneca’s PLATO trial for Brilinta

US DoJ closes investigation into AstraZeneca’s PLATO trial for Brilinta

19-08-2014

Anglo-Swedish drug major AstraZeneca has received confirmation from the US Department of Justice that…

AstraZenecaBrilintaBrilintaCardio-vascularLegalPharmaceuticalUKUSA

Atherothrombotic diseases market to grow to $47 billion in 2022

Atherothrombotic diseases market to grow to $47 billion in 2022

23-12-2013

The launch of numerous add-on therapies in the atherothrombotic diseases market (incorporating pharmacotherapies…

AstraZenecaBayerBrilintaCardio-vascularEli LillyevacetrapibGlobalMarkets & MarketingPharmaceuticalXarelto

FT Pharma 2013: AstraZeneca CEO Pascal Soriot on Brilinta, MedImmune and the UK’s ‘Golden Triangle’

FT Pharma 2013: AstraZeneca CEO Pascal Soriot on Brilinta, MedImmune and the UK’s ‘Golden Triangle’

03-12-2013

The UK’s ‘Golden Triangle’ of biotech innovation can compete on the world stage, AstraZeneca (LSE:…

AstraZenecaBoardroomBrilintaInterviewsPharmaceuticalUK

AstraZeneca initiates two additional global studies with Brilinta

AstraZeneca initiates two additional global studies with Brilinta

14-11-2013

Anglo-Swedish drug major AstraZeneca plans to conduct two new clinical studies as part of PARTHENON,…

AstraZenecaBrilintaCardio-vascularPharmaceuticalResearch

AstraZeneca “cooperating” with US DoJ inquiry into Brilinta trial

AstraZeneca “cooperating” with US DoJ inquiry into Brilinta trial

01-11-2013

AstraZeneca said it is cooperating with the US Department of Justice after an investigation has been…

AstraZenecaBrilintaCardio-vascularEuropeLegalPharmaceutical

AstraZeneca records fall in 2nd-qtr revenue but 21% rise in China sales

01-08-2013

Anglo-Swedish drug major AstraZeneca (LSE: AZN) has reported second-quarter 2013 financial results with…

AstraZenecaBrilintaByettaEuropeFinancialOnglyzaPharmaceuticalSymbicort

New Zealand to fund AstraZeneca's Brilinta for acute coronary syndromes

10-06-2013

New Zealand's Pharmaceutical Management Agency, PHARMAC, says it has reached an agreement with the local…

Asia-PacificAstraZenecaBrilintaCardio-vascularPharmaceuticalPricingRegulation

Proposal to list AstraZeneca's Brilinta in New Zealand

26-03-2013

New Zealand's Pharmaceutical Management Agency, PHARMAC, is seeking feedback on a proposal to fund the…

Asia-PacificAstraZenecaBrilintaCardio-vascularFinancialHealthcarePharmaceuticalPricingticagrelor

AstraZeneca management shakeup sign of major restructuring leading to stock recovery, say analysts

17-01-2013

The management changes at Anglo-Swedish drug major AstraZeneca (LSE: AZN) announced this week do not…

AstraZenecaBrilintaBriliqueFinancialManagementMergers & AcquisitionsPharmaceuticalShire

AstraZeneca's Brilinta rolls out in India

18-10-2012

The Indian subsidiary of Anglo-Swedish drug major AstraZeneca (LSE: AZN) yesterday launched its patented…

Asia-PacificAstraZenecaBrilintaCardio-vascularMarkets & MarketingPharmaceutical

STEMI guidelines now recommend AstraZeneca's ticagrelor as first-line treatment option

30-08-2012

Anglo-Swedish drug major AstraZeneca (LSE: AZN) said yesterday that ticagrelor, its oral antiplatelet…

AstraZenecaBrilintaBriliqueCardio-vascularEffientEli LillyPharmaceuticalRegulation

Updated AHA/ACCF guidelines for unstable angina include newest blood-thinning drug

18-07-2012

Ticagrelor, Anglo-Swedish drug major AstraZeneca's (LSE: AZN) blood-thinning drug Brilique/Brilinta which…

AspirinAstraZenecaBrilintaBriliqueCardio-vascularClopidogrelNorth AmericaPharmaceuticalprasugrelRegulation

AstraZeneca's ticagrelor cost effective versus clopidogrel

21-06-2012

Anglo-Swedish drug major AstraZeneca yesterday announced that full data results of the PLATO health economics…

AstraZenecaBrilintaBriliqueCardio-vascularClopidogrelPharmaceuticalPricingticagrelor

Nine news Rx drugs added to Australian PBS listings

22-02-2012

Australia’s Federal Minister for Health, Tanya Plibersek, yesterday announced the listing of nine…

Asia-PacificAstraZenecaBrilintaGlaxoSmithKlinePharmaceuticalPricingRegulationZinnat

Back to top